Press Releases
We’re Delivering the Promise of Healthier Lives.
CURE PHARMACEUTICALÂ
Press Releases
We specialize in optimal formulations to achieve targeted release and exposure of medications.​
CURE Pharmaceutical to Present at 2018 Biotech Showcase
OXNARD, Calif., Jan. 03, 2018 (GLOBE NEWSWIRE)
Cure Pharmaceutical Enters Into Product Development Agreement with Therapix Biosciences To Develop Cannabinoid-Based Product For Sleep Disorders
CURE to Manufacture Therapix Proprietary Entourage Formulation (Dronabinol and PEA)-Based Product Using Proprietary CureFilm
CURE Pharmaceutical Subsidiary, Oak Therapeutics, Completes Critical Milestone in Phase 1 of NIH Grant to Develop Oral Dissolvable Strip for Tuberculosis
OXNARD, Calif., Aug. 22, 2017 (GLOBE NEWSWIRE)
CURE Pharmaceutical Launches New Academic Partnership Program Providing the Company
OXNARD, Calif., Sept. 06, 2017 (GLOBE NEWSWIRE)
CURE Pharmaceutical Enters Partnership to Distribute New Erectile Dysfunction Drug Using Company
OXNARD, Calif., Aug. 10, 2017 (GLOBE NEWSWIRE)
CURE Pharmaceutical Appoints CannaKids CEO and Cannabis Cancer Advocate Tracy Ryan to Advisory Board
OXNARD, Calif., June 27, 2017 (GLOBE NEWSWIRE)
CURE Pharmaceutical & Therapix Biosciences Signs MOU with Israel
OXNARD, Calif. and TEL AVIV, Israel, July 11, 2017 (GLOBE NEWSWIRE)
Getting Healthy, Not High: Using Cannabis to Fight Cancer
Leading OTF Manufacturer CURE Pharmaceutical Comments on New Report Showing Exponential Growth in Thin Film Drug Manufacturing Market
OXNARD, Calif., June 07, 2017 (GLOBE NEWSWIRE)
Cure Pharma
In-Pharmatechnologist covered CURE
CURE Pharmaceutical and CannaKids Announce Research Collaboration with Technion-Israel Institute of Technology on Cancer-Fighting Cannabinoids
OXNARD, Calif., May 31, 2017 (GLOBE NEWSWIRE)
CURE Pharmaceutical Receives First Purchase Order Stemming from Product Development and License Agreement with Pharmaceutical Company, Meroven LTD
OXNARD, Calif., May 24, 2017 (GLOBE NEWSWIRE)
CURE Pharmaceutical Strengthens Senior Leadership Team with Appointment of Industry Veteran Richard Serbin as Head of Global Corporate Development
OXNARD, Calif., May 09, 2017 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (